Archive for January, 2004
Purple Haze
Purple Haze
The prospects of a medicinal version of cannabis being produced have never been better but manufacturers are still trying to see through the haze of ethical and practical issues.
Financial Snapshot For December 2003
Financial Snapshot For December 2003
Bulls Charge Ahead
What’s Next for Pharma?
What’s Next for Pharma?
Experts from the Tufts Center for the Study of Drug Development discuss the outlook for R&D, mergers, and the FDA’s changing role
India: Big Pharma’s New Promised Land?
India: Big Pharma’s New Promised Land?
For years, software companies have known that they can slash costs by hiring eager, smart, and inexpensive programmers and engineers in India. Following in software’s footsteps, corporations providing telephone support and back-office services soon saw the virtues of India’s well-trained workforce as well. Now, Big Pharma is discovering the same [...]
Genetically engineered Glofish spark controversy
Genetically engineered Glofish spark controversy
The nation’s first genetically engineered pet glows in the dark and has been lighting up cash registers in Michigan pet shops. But Glofish, created by splicing a sea anemone gene into a zebra fish, may not be available for long.
Feeling Lucky?
Feeling Lucky?
Counterfeiters have moved beyond bogus currency and fake designer handbags into the lucrative world of prescription drugs, setting off a technology race to foil copycats who profit on phony pharmaceuticals.
